Isabelle ETIENNE, MD
University Hospital, Rouen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Isabelle ETIENNE, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT00811915 · Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney TransplantationUniversity Hospital, Rouen · terminated · Kidney Transplantation · principal investigator
- Ph3NCT00213590 · Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant PatientsUniversity Hospital, Rouen · completed · Kidney Transplantation, Primary Prevention, Kidney Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.